By advancing next-generation AI/DL-based pathology analysis platforms and promoting the use of the newly developed pathological biomarkers in clinical settings, NEC and Biomy aim to contribute ...
In this study, we demonstrate the feasibility of generating virtual stains for hematoxylin and eosin (H&E) and a multiplex immunofluorescence (mIF) immuno-oncology panel (DAPI, PanCK, PD-L1, CD3, and ...